Techiexpert.com
No Result
View All Result
  • Tech
  • Startup
  • Artificial Intelligence
  • IOT
  • Big Data
  • Cloud
  • Data Analytics
  • Machine Learning
  • Blockchain
No Result
View All Result
  • Tech
  • Startup
  • Artificial Intelligence
  • IOT
  • Big Data
  • Cloud
  • Data Analytics
  • Machine Learning
  • Blockchain
No Result
View All Result
Techiexpert.com
No Result
View All Result

Artificial intelligence to improve drug combination design

Sony T by Sony T
October 1, 2018
in Artificial Intelligence
0
Artificial intelligence to improve drug combination design 1
10
SHARES
139
VIEWS
Share on FacebookShare on Twitter

A new auto-commentary that was published recently in the journal SLAS Technology talks about how an emerging area of artificial intelligence, especially the analysis of small systems-of-interest specific datasets, can now be used to significantly improve drug development and personalized medicine.

This new auto-commentary builds on a previous study that was recently published by the authors in Science Translational Medicine about an artificial intelligence (AI) platform, known as Quadratic Phenotypic Optimization Platform (QPOP), that has the potential to substantially improve combination therapy in bortezomib-resistant multiple myeloma to identify the best drug combinations for patients who suffer from individual multiple myeloma.

There’s now significant proof that complex diseases, such as cancer, often need effective drug combinations to achieve any significant therapeutic impact. As the drugs in these drug combination therapies become more and more specific to molecular targets, it makes designing effective drug combinations and also choosing the right drug combination for the right patient more and more difficult.

Artificial intelligence is now leading to a positive impact on drug development and personalized medicine. Along with the ability to efficiently analyze the small datasets that have the ability to focus on the specific disease of interest, QPOP and other small dataset-based AI platforms can intelligently design optimal drug combinations that are effectiver and based on real experimental data and not on the mechanistic assumptions or predictive modeling.

Additionally, due to the efficiency of the platform, QPOP can also used for the important patient samples to help optimize and personalize combination therapy.

If you like this article, then share your views in the comment below!

Tags: AI usecasesdrugspharmaceutical sectors
Share4Tweet3Share1Pin1

Popular this week

  • Y2Mate.com 2023: How to Download Videos and Audios

    Y2Mate.com 2023: How to Download Videos and Audios

    513 shares
    Share 205 Tweet 128
  • Renesas Expands IoT Footprint with Sequans Acquisition

    3123 shares
    Share 1249 Tweet 781
  • Global Cybersecurity Innovator, Zeron, Secures $500,000 in Seed Funding

    71 shares
    Share 28 Tweet 18
  • Citi’s Token Service Paves the Path for Blockchain Adoption

    67 shares
    Share 27 Tweet 17
  • Top 10 Omegle Alternatives you might like

    422 shares
    Share 169 Tweet 106
  • What is windows modules installer ? How to Enable/Disable

    174 shares
    Share 70 Tweet 44

Popular Sections On Techiexpert

Artificial Intelligence Big Data Blockchain Blogging Cloud Computing Data Analytics How to Internet Of Things Machine Learning Marketing Trends Social Media Startup news Tech news

Latest Stories on Techiexpert

Top 10 Innovative Indian AI startups

Top 10 Innovative Indian AI startups
Share4Tweet3Share1Pin1

Connect Me to My Internet Provider’s Support Team

Internet Provider
Share4Tweet3Share1Pin1

How to Get Crunchyroll on any Device?

5 Must-Have Uploader Apps to Streamline Your Workflow
Share4Tweet3Share1Pin1
  • Privacy Policy
  • About Us
  • Contact us
  • Cookie Policy
  • Write For Us

© 2016-2022 All Rights Reserved

No Result
View All Result
  • Tech
  • Startup
  • Artificial Intelligence
  • IOT
  • Big Data
  • Cloud
  • Data Analytics
  • Machine Learning
  • Blockchain

© 2016-2022 All Rights Reserved

Cookie Law Notice
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
SAVE & ACCEPT
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.